Esta traducción se está preparando. Mientras tanto, mostramos temporalmente la versión original en inglés.
Negocios · 17/6/20241 min de lectura
Diabetic Foot Infections: Developing Drugs for Treatment; Guidance for Industry; Availability
Traducción automática local · Idioma original de la fuente
Resumen
The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled "Diabetic Foot Infections: Developing Drugs for Treatment." The purpose of this guidance is to assist sponsors in the clinical development of drugs for the treatment of diabetic foot infections (DFI) without concomitant bone and joint involvement. This guidance finalizes and replaces the draft guidance of the same title issued on October 17, 2023.
Idioma original de la fuente: Federal Register — Food and Drug AdministrationAbrir el comunicado original →